Conversational AI Models in Periodontitis Classification
Launched by NECMETTIN ERBAKAN UNIVERSITY · Jun 23, 2023
Trial Information
Current as of June 06, 2025
Completed
Keywords
ClinConnect Summary
The descriptive pilot research will be based on an analysis of the baseline digital record and subsequent stage, extent, and grade characterization of 75 untreated patients diagnosed with periodontitis. All cases will be evaluated by 4 examiners and the obtained standardized diagnosis for each case. The information will be used to determine the stage, grade, and extent of 75 periodontitis cases will be copied directly for each case as input to a large AI model called ChatGPT (https://chat.openai.com/), followed by query: "What is the stage, grade, and extent of periodontitis?" The received ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The cases whose clinical, photographic, and radiological records are excellent quality and have good diagnostic sensitivity.
- Exclusion Criteria:
- • Acute periodontal lesions
- • gingival diseases
- • the presence of dental implants
- • periodontitis as a manifestation of systemic diseases were considered as exclusion criteria.
About Necmettin Erbakan University
Necmettin Erbakan University is a prominent academic institution dedicated to advancing health sciences and research through innovative clinical trials. With a commitment to excellence in education and research, the university leverages its multidisciplinary approach to foster collaborations that enhance patient care and medical advancements. By conducting rigorous clinical studies, Necmettin Erbakan University seeks to contribute valuable insights to the medical community, ultimately improving treatment outcomes and fostering evidence-based practices in healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Konya, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported